KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addus HomeCare (ADUS) Gains from Sales and Divestitures (2016 - 2024)

Historic Gains from Sales and Divestitures for Addus HomeCare (ADUS) over the last 14 years, with Q4 2024 value amounting to $103000.0.

  • Addus HomeCare's Gains from Sales and Divestitures rose 842.11% to $103000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $103000.0, marking a year-over-year increase of 842.11%. This contributed to the annual value of $103000.0 for FY2024, which is 842.11% up from last year.
  • Latest data reveals that Addus HomeCare reported Gains from Sales and Divestitures of $103000.0 as of Q4 2024, which was up 842.11% from $95000.0 recorded in Q4 2023.
  • Over the past 5 years, Addus HomeCare's Gains from Sales and Divestitures peaked at $103000.0 during Q4 2024, and registered a low of $74000.0 during Q4 2022.
  • In the last 5 years, Addus HomeCare's Gains from Sales and Divestitures had a median value of $77000.0 in 2020 and averaged $85000.0.
  • Per our database at Business Quant, Addus HomeCare's Gains from Sales and Divestitures plummeted by 263.16% in 2022 and then skyrocketed by 2837.84% in 2023.
  • Quarter analysis of 5 years shows Addus HomeCare's Gains from Sales and Divestitures stood at $77000.0 in 2020, then fell by 1.3% to $76000.0 in 2021, then fell by 2.63% to $74000.0 in 2022, then increased by 28.38% to $95000.0 in 2023, then increased by 8.42% to $103000.0 in 2024.
  • Its Gains from Sales and Divestitures was $103000.0 in Q4 2024, compared to $95000.0 in Q4 2023 and $74000.0 in Q4 2022.